Newsfiscal.ai
H.C. Wainwright Maintains Hold Rating on Evommune
· Published
Article summary
Investment firm H.C. Wainwright has reaffirmed its 'Hold' rating for Evommune, Inc. (EVMN).
An excerpt from the original article.Analyzed by WAPE AI.
Preparing English content…
Comments —
Loading comments…